Cite
Sessa M, Mascolo A, Scavone C, et al. Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study. Front Pharmacol. 2018;9:1212doi: 10.3389/fphar.2018.01212.
Sessa, M., Mascolo, A., Scavone, C., Perone, I., Di Giorgio, A., Tari, M., Fucile, A., De Angelis, A., Rasmussen, D. B., Jensen, M. T., Kragholm, K., Rossi, F., Capuano, A., & Sportiello, L. (2018). Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study. Frontiers in pharmacology, 91212. https://doi.org/10.3389/fphar.2018.01212
Sessa, Maurizio, et al. "Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study." Frontiers in pharmacology vol. 9 (2018): 1212. doi: https://doi.org/10.3389/fphar.2018.01212
Sessa M, Mascolo A, Scavone C, Perone I, Di Giorgio A, Tari M, Fucile A, De Angelis A, Rasmussen DB, Jensen MT, Kragholm K, Rossi F, Capuano A, Sportiello L. Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study. Front Pharmacol. 2018 Oct 25;9:1212. doi: 10.3389/fphar.2018.01212. eCollection 2018. PMID: 30459608; PMCID: PMC6232895.
Copy
Download .nbib